Form EFFECT MiNK Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 11, 2025 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MiNK Therapeutics joins ARPA-H's $87M room-temperature cell therapy program
- Graphano Energy Provides Update on Proposed Earn-In Transaction with 3D Genesis Technologies
- Concierra Legal Announces Founder’s 15th Consecutive Texas Super Lawyers Selection with Top 50 Women and Top 100 DFW Honors
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
